Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.1K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

788
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
788
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

790
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
790
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

720
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
720

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased diffusion capacity maintains arterial saturation during exercise in the Quechua Indians of Chilean Altiplano.

American journal of human biology : the official journal of the Human Biology Council·2017
Same author

Low Back Pain in a Tennis Player.

The Physician and sportsmedicine·2016
Same author

Cluster Headache Among Athletes.

The Physician and sportsmedicine·2016
Same author

Chronic Shoulder Pain in a Volleyball Player.

The Physician and sportsmedicine·2016
Same author

Rattlesnakes: The Animal and the Venom (Part 1 of 2).

The Physician and sportsmedicine·2016
Same author

First Aid and Management of Rattlesnake Bites (Part 2 of 2).

The Physician and sportsmedicine·2016
Same journal

Injury surveillance during the 2024 under 20s Men's European Field Lacrosse Championships.

The Physician and sportsmedicine·2026
Same journal

Understanding health insurance and the delay in care for partial meniscectomies: a comparison between public and private coverage.

The Physician and sportsmedicine·2026
Same journal

Injury incidence and risk factors in youth American football versus soccer: a national emergency department analysis.

The Physician and sportsmedicine·2026
Same journal

Links between concussion history, hypertension, and hypertension contributing factors among adolescent football athletes.

The Physician and sportsmedicine·2026
Same journal

Core muscle endurance and balance as predictors of lateral ankle sprain in adolescent team-sport athletes: a prospective cohort study.

The Physician and sportsmedicine·2026
Same journal

Impact of Achilles tendon rupture on performance and career outcomes in NFL players: a matched cohort study.

The Physician and sportsmedicine·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

Point-of-Care Lung Ultrasound in Adults: Image Acquisition
09:17

Point-of-Care Lung Ultrasound in Adults: Image Acquisition

Published on: March 3, 2023

8.0K

High-Altitude Pulmonary Edema: The Disguised Killer.

R B Schoene, M D Bracker

    The Physician and Sportsmedicine
    |July 13, 2016
    PubMed
    Summary
    This summary is machine-generated.

    High-altitude pulmonary edema affects 1-2% of travelers above 10,000 ft. Gradual acclimatization is key to preventing this severe, potentially fatal illness.

    More Related Videos

    Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
    05:56

    Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

    Published on: September 6, 2024

    6.9K
    Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
    08:27

    Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

    Published on: May 21, 2018

    11.5K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    Point-of-Care Lung Ultrasound in Adults: Image Acquisition
    09:17

    Point-of-Care Lung Ultrasound in Adults: Image Acquisition

    Published on: March 3, 2023

    8.0K
    Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
    05:56

    Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

    Published on: September 6, 2024

    6.9K
    Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
    08:27

    Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

    Published on: May 21, 2018

    11.5K

    Area of Science:

    • Environmental Medicine
    • Pulmonary Medicine
    • Altitude Physiology

    Background:

    • High-altitude pulmonary edema (HAPE) affects 1-2% of individuals ascending above 10,000-11,000 ft.
    • HAPE represents a severe manifestation of altitude-related illnesses, with symptoms ranging from subtle to overt.
    • Rapid progression to coma and death is possible if untreated.

    Purpose of the Study:

    • To review the signs, symptoms, and recognition of HAPE.
    • To discuss the underlying pathophysiology of HAPE.
    • To outline strategies for the prevention and management of HAPE.

    Main Methods:

    • Literature review of high-altitude illnesses, focusing on HAPE.
    • Analysis of clinical presentations and progression of HAPE.
    • Synthesis of current knowledge on HAPE pathophysiology, prevention, and treatment.

    Main Results:

    • HAPE symptoms can be subtle or overt and progress rapidly.
    • Acclimatization, involving slow ascent, is the primary preventive measure.
    • Understanding pathophysiology aids in recognizing and managing HAPE.

    Conclusions:

    • HAPE is an avoidable but potentially fatal condition.
    • Recognizing early signs and symptoms is crucial for timely intervention.
    • Effective prevention and management rely on proper acclimatization and prompt treatment.